Skip to main content
Fig. 1 | BMC Pulmonary Medicine

Fig. 1

From: Combination therapy with budesonide and N-acetylcysteine ameliorates LPS-induced ALI by attenuating neutrophil recruitment through the miR-196b-5p/Socs3 molecular axis

Fig. 1

Combination therapy with BUD and NAC improves LPS-induced ALI. A Histopathological changes of lung injury and pathology scores of lung tissues (n = 6), B pulmonary edema level(n = 6), C Evans blue staining for alveolar permeability(n = 6), D MPO activity of lung tissue(n = 6), E neutrophil count in BALF(n = 6), F-I ELISA for cytokines in BALF(n = 6). compared with the NC group, ** P < 0.01, *** P < 0.001; compared with the ALI group, # P < 0.05, ## P < 0.01, ### P < 0.001; compared with the ALI + BUD group, $ P < 0.05, $$ P < 0.01, $$$ P < 0.001; compared with the ALI + NAC group, & P < 0.05, && P < 0.01, &&& P < 0.001

Back to article page